Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Treatment Sequencing With CAR T-cell Therapies and Bispecific Antibodies on Long-term Survival in 4L+ RRMM in the United States: A Simulation Model.

Clinical lymphoma, myeloma & leukemia·2026
Same author

A plain language summary describing how talquetamab affects the way people with multiple myeloma feel and function in the MonumenTAL-1 study.

Future oncology (London, England)·2026
Same author

Detection of cytokine release syndrome using wearables and cytokine profiling following CAR-T therapy for myeloma.

JCI insight·2026
Same author

Infections in patients receiving daratumumab for newly diagnosed multiple myeloma: a pooled analysis of MAIA and ALCYONE.

Blood advances·2026
Same author

Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab.

Haematologica·2026
Same author

Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference.

American journal of hematology·2026

Related Experiment Video

Updated: Mar 25, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K

Diagnostic Advances in Multiple Myeloma.

Kevin Barley1, Ajai Chari2

  • 1Multiple Myeloma Program, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, Box 1185, New York, NY, 10029, USA.

Current Hematologic Malignancy Reports
|February 29, 2016
PubMed
Summary

Recent advances enhance multiple myeloma (MM) diagnosis. New assays and imaging techniques improve detection of light chain MM, extramedullary disease, and bone lesions, enabling earlier treatment.

Keywords:
DiagnosisExtramedullary diseaseFree light chainsHevyLiteMultiple myelomaWhole body low-dose CT

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.6K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.2K

Related Experiment Videos

Last Updated: Mar 25, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.6K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.2K

Area of Science:

  • Hematology
  • Medical Diagnostics
  • Oncology

Background:

  • Multiple myeloma (MM) diagnosis has seen recent advancements.
  • Serum free light chains aid in diagnosing light chain MM.
  • Challenges persist in serologic diagnosis, especially for IgA MM.

Purpose of the Study:

  • To review recent diagnostic advances in multiple myeloma.
  • To highlight improved serologic and imaging techniques for MM detection.

Main Methods:

  • Utilizing serum free light chain assays.
  • Employing novel heavy/light chain assays.
  • Advancing imaging modalities like low-dose CT, MRI, and PET/CT.

Main Results:

  • Improved accuracy in diagnosing light chain MM and IgA MM.
  • Enhanced detection of extramedullary disease (CNS, pleura, ascites).
  • Increased sensitivity in identifying lytic bone lesions with advanced imaging.

Conclusions:

  • New diagnostic tools offer improved accuracy and sensitivity for MM.
  • Advanced imaging facilitates earlier treatment and monitoring of osseous and extramedullary disease.
  • Future techniques like fused PET/MRI promise further diagnostic enhancement.